Physician profile
Scott W Bloom
NPI 1932428059
$30,843.67
in general payments reported to CMS, 2019-2025
12 companies · $4,570 in 2025
The $4,570 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,351 · 2020: $426 · 2021: $13K · 2022: $2,954 · 2023: $221 · 2024: $4,683 · 2025: $4,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $1,474.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,989.20 | 2019-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $205.79 | 2024 | Spyglass Discover |
| W. L. Gore & Associates, INC. | $133.09 | 2020-2024 | Gore Enform Preperitoneal Biomaterial |
| Davol INC. | $99.99 | 2019 | |
| Asensus Surgical, INC. | $91.01 | 2019 | |
| Acera Surgical, INC. | $79.62 | 2024-2025 | Restrata Wound Matrix |
| Conmed Corporation | $66.67 | 2019 | |
| Ethicon US, LLC | $63.79 | 2020-2022 | |
| Smith+Nephew, INC. | $43.41 | 2023-2024 | Pico 14, Stravix Pl |
| Kerecis Limited | $37.08 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Allergan, INC. | $17.11 | 2022 | |
| Guard Medical INC. | $16.91 | 2024 | Npseal Large |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.